Vienna Vascular Liver Disease Study

Launched by MEDICAL UNIVERSITY OF VIENNA · May 17, 2018

Keywords

ClinConnect Summary

The Vienna Vascular Liver Disease Study is a clinical trial designed to better understand various vascular liver diseases, such as Portal Vein Thrombosis and Budd-Chiari Syndrome. The researchers aim to learn about the causes, risk factors, and how well the liver is functioning in patients with these conditions. They will also look for new ways to measure liver health through tests on blood, urine, and other samples. This study is open to adults aged 18 to 100 who have been diagnosed with a vascular liver disease through imaging tests or liver tissue samples, and participants will need to give their written consent to join.

If you decide to participate, you can expect to undergo various evaluations to assess your liver health and blood clotting status. The findings from this study could lead to a better understanding of these diseases and potentially improve future treatments. It’s important to note that this trial is currently recruiting participants, and anyone who decides to join will be contributing valuable information that could help others facing similar health issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of a vascular liver disease by imaging (sonography, CT, MRI), transient elastography or liver histology
• • PVT: Portal vein thrombosis
• • NCPH: non-cirrhotic Portal Hypertension
• • PSVD: porto-sinusoidal vascular disorder
• • BCS: Budd-Chiari-Syndrome
• • SOS: sinusoidal occlusive disease
• • HHT: hereditary hemorrhagic teleangiectasia
• • CIRCAD: cirrhosis cardiaque
• • Age \>18 years and \<100 years
• • Written informed consent obtained
• Exclusion Criteria:
• • - withdrawal of written informed consent